Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein α-subunits with different potencies

Molecular Pharmacology

Volumn 57, Issue 5, 2000, Pages 1000-1010

  Prather, Paul L ^a   Martin, Nancy A ^a   Breivogel, Christopher S ^b   Childers, Steven R ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PERTUSSIS TOXIN; PHOSPHORUS 32; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NEUROPHARMACOLOGY; NONHUMAN; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

ANIMALS; AZIDES; CALCIUM CHANNEL BLOCKERS; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; MALE; MORPHOLINES; NAPHTHALENES; PHOSPHORUS RADIOISOTOPES; PHOTOAFFINITY LABELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VIRULENCE FACTORS, BORDETELLA;

EID: 0034056416     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G and Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641.
2. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Breivogel CS and Childers SR (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5:417-431.
4. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273:16865-16873.
5. Breivogel CS, Sim LJ and Childers SR (1997) Regional differences in cannabinoid receptor/G protein coupling in rat brain. J Pharmacol Exp Ther 282:1632-1642.
6. 32P]GTP labeling of multiple G protein α subunits. J Neurochem 64:2534-2543.
7. Cook SA, Welch SP, Lichtman AH and Martin BR (1995) Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sci 56:2049-2056.
8. Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151-178.
9. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chancy MO, Koppel GA and Brownstein M 11998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284:291-297.
10. Gifford AN, Tang Y, Galley SJ, Volkow ND, Lan R and Makriyannis A (1997) Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci Lett 28:84-86.
11. Glass M and Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327-5333.
12. Goetzl EJ, Shames RS, Yang J, Birke FW, Liu YF and Albert PR (1994) Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. J Biol Chem 269:809-812.
13. Gruol DL, Netzeband JG, Qiu Z, Campbell IL and Parsons KL (1996) Cannabinoids and interleukin-6 enhance the response to NMDA in developing CNS neurons. Adv Exp Med Biol 402:111-117
14. Gudermann T, Schoneberg T and Schultz G (1997) Functional and structrual complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci 20:399-427.
15. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR and Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
16. Howlett AC (1984) Inhibition of neuroblastoma adenylyl cyclase by cannabinoid and nantradol compounds. Life Sci 35:1803-1810.
17. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
18. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G and Wittig B (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature (Lond) 353:43-48.
19. Laugwitz KL, Offermanns S, Spicher K and Schultz G (1993) μ-and δ-Opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma cell lines. Neuron 10:233-242.
20. 12 in GH4C1 pituitary cells. J Biol Chem 269: 13880-13886.
21. Mackie K, Lai Y, Westenbroek R and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
22. Maneuf YP and Brotchie JM (1997) Paradoxical action of the cannabinoid WIN 55212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br J Pharmacol 120:1397-1398.
23. Matesic DF, Manning DR and Luthin GR (1991) Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins. Mol Pharmacol 40:347-353.
24. Mclntire WE, Dingus J, Schey KL and Hildebrandt JD (1998) Characterization of the major bovine brain Go α isoforms. J Biol Chem 273:33135-33141.
25. 2. Biochem J 267:391-396.
26. Munro S, Thomas KL and Abu-Sharr (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
27. Offermanns S, Wieland T, Homann D, Sandmann J, Bombien E, Spicher K, Schultz G and Jakobs KH (1994) Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. Mol Pharmacol 45:890-898.
28. Pacheco MA, Ward SJ and Childers SR (1993) Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res 603:102-110.
29. Prather PL, Loh HH and Law PY (1994a) Interaction of δ-opioid receptors with multiple G proteins. A non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol 45:997-1003.
30. α subunit and is similar to that of other opioid receptors. Mol Brain Res 29:336-346.
31. Prather PL, McGinn TM, Erickson LJ, Evans CJ, Loh HH and Law PY (1994b) Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J Biol Chem 269:21293-21302.
32. Ribeiro-Neto FA and Rodbell M (1989) Pertussis toxin induces structural changes in G alpha proteins independently of ADP-ribosylation. Proc Natl Acad Sci USA 86:2577-2581.
33. 35S]thio)triphosphate binding in rat brain membranes. Life Sci 59:659-668.
34. Shire D, Carillion C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D and Ferrara P (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270:3726-3731.
35. α C-terminal antibodies. Proc Natl Acad Sci USA 86: 7809-7813.
36. Spiegel AM (1990) Antibodies as probes of the structure and function of heterotrimeric GTP-binding proteins, in ADP-Ribosylating Toxins and G-Proteins, pp 207-224, American Society for Microbiology, Washington, DC.
37. Spicher K, Nuernberg B, Jager B, Rosenthal W and Schultz G (1992) Heterogeneity of three electrophoretically distinct Go alpha-subunits in mammalian brain. FEBS Lett 307:215-218.
38. Standifer KM and Pasternak GW (1997) G proteins and opioid receptor-mediated signalling. Cell Signal 9:237-248.
39. Sternweis PC and Robishaw JD (1984) Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem 259:13806-13813.
40. Waldhoer M, Wise A, Milligan G, Freissmuth M and Nanoff C (1999) Kinetics of ternary complex formation with fusion proteins composed of the A(1)-adenosine receptor and G protein alpha-subunits. J Biol Chem 274:30571-30579.